Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Express Scripts
Colorcon
Boehringer Ingelheim
Mallinckrodt

Last Updated: July 1, 2022

CLINICAL TRIALS PROFILE FOR MESTINON


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Mestinon

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00075101 ↗ Sleep, Fatigue, and Dexamethosone in Children With Leukemia Completed National Institute of Nursing Research (NINR) Phase 3 2000-09-01 The purpose of this study is to determine the relationship between dexamethosone (steroid) and children's sleep and fatigue.
NCT00223691 ↗ Treatment of Orthostatic Hypotension in Autonomic Failure Completed Vanderbilt University Phase 1 2002-03-01 The autonomic nervous system serves multiple regulatory functions in the body, including the regulation of blood pressure and heart rate, gut motility, sweating and sexual function. There are several diseases characterized by abnormal function of the autonomic nervous system. Medications can also alter autonomic function. Impairment of the autonomic nervous system by diseases or drugs may lead to several symptoms, including blood pressure problems (e.g., high blood pressure lying down and low blood pressure on standing), sweating abnormalities, constipation or diarrhea and sexual dysfunction. Because treatment options for these patients are limited. We propose to study patients autonomic failure and low blood pressure upon standing and determine the cause of their disease by history and examination and their response to autonomic testing which have already been standardized in our laboratory. Based on their possible cause, we will tests different medications that may alleviate their symptoms.
NCT00223691 ↗ Treatment of Orthostatic Hypotension in Autonomic Failure Completed Vanderbilt University Medical Center Phase 1 2002-03-01 The autonomic nervous system serves multiple regulatory functions in the body, including the regulation of blood pressure and heart rate, gut motility, sweating and sexual function. There are several diseases characterized by abnormal function of the autonomic nervous system. Medications can also alter autonomic function. Impairment of the autonomic nervous system by diseases or drugs may lead to several symptoms, including blood pressure problems (e.g., high blood pressure lying down and low blood pressure on standing), sweating abnormalities, constipation or diarrhea and sexual dysfunction. Because treatment options for these patients are limited. We propose to study patients autonomic failure and low blood pressure upon standing and determine the cause of their disease by history and examination and their response to autonomic testing which have already been standardized in our laboratory. Based on their possible cause, we will tests different medications that may alleviate their symptoms.
NCT00276406 ↗ Use of Pyridostigmine for Constipation in Diabetics Completed National Center for Research Resources (NCRR) Phase 1/Phase 2 2006-05-01 Doctors at Mayo Clinic are doing this study to learn if pyridostigmine, a drug, affects the speed at which food travels through the stomach, intestines and colon, and if pyridostigmine improves constipation symptoms in patients with diabetes. Pyridostigmine has been approved by the Food and Drug Administration (FDA) for routine clinical use, however, its use as proposed in this study is considered investigational.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Mestinon

Condition Name

Condition Name for Mestinon
Intervention Trials
Diabetes Mellitus 3
Fibromyalgia 2
Orthostatic Hypotension 2
CD4+ T Lymphocytopenia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Mestinon
Intervention Trials
Diabetes Mellitus 3
Tachycardia 3
Postural Orthostatic Tachycardia Syndrome 3
HIV Infections 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Mestinon

Trials by Country

Trials by Country for Mestinon
Location Trials
United States 12
Mexico 5
Denmark 2
Belgium 1
Switzerland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Mestinon
Location Trials
New York 3
Tennessee 3
Florida 2
Virginia 1
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Mestinon

Clinical Trial Phase

Clinical Trial Phase for Mestinon
Clinical Trial Phase Trials
Phase 4 2
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Mestinon
Clinical Trial Phase Trials
Completed 10
Active, not recruiting 2
Terminated 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Mestinon

Sponsor Name

Sponsor Name for Mestinon
Sponsor Trials
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 3
Vanderbilt University Medical Center 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Mestinon
Sponsor Trials
Other 34
NIH 8
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Boehringer Ingelheim
Dow
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.